Literature DB >> 18634144

Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments.

Natacha Thelier1, Noémie Assous, Chantal Job-Deslandre, Olivier Meyer, Thomas Bardin, Philippe Orcel, Frédéric Lioté, Maxime Dougados, Andre Kahan, Yannick Allanore.   

Abstract

OBJECTIVE: To analyze the pattern of osteoarticular lesions in patients with sarcoidosis hospitalized in 4 rheumatology departments.
METHODS: We carried out a systematic retrospective analysis of cases with sarcoidosis admitted in the last 10 years, using hospital databases. Two distinct groups were defined from the outset: patients with Löfgren's syndrome (LS) or sarcoid rheumatism (SR). We assessed the following items: distribution of arthritis, chronicity, systemic manifestations, biochemical and immunological measures.
RESULTS: We included 100 patients (75% women); 43% had LS and 57% SR. Osteoarticular symptoms revealed the disease in 85% of patients. The patients in the LS group were younger than those in the SR group (41 +/- 9 vs 48 +/- 13 yrs; p < 0.006) and were more likely to have oligoarthritis involving ankles (58% vs 32%; p = 0.04) and high C-reactive protein concentrations (63% vs 33%; p < 0.005). Patients with SR presented osteoarticular symptoms in the form of oligoarthritis (32%), polyarthritis (32%), bony erosion in 8/57 (14%), and osteitis in 9/57 (16%). Lung interstitial involvement was more frequent in the SR group than in the LS group (38% vs 18%; p = 0.03). Chronic polyarthritis was associated with the detection of rheumatoid factor (p = 0.004). Osteitis occurred in older patients (p = 0.02).
CONCLUSION: SR was the most frequent manifestation leading to hospitalization; it was characterized by oligoarthritis and polyarthritis and associated with interstitial lung involvement. Osseous involvement occurred in a quarter of SR patients with similar frequency of erosions targeting the distal small bones and osteitis. These latter occurred at a later age.

Entities:  

Mesh:

Year:  2008        PMID: 18634144

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  18F-FDG PET/CT detects systemic involvement in sarcoidosis.

Authors:  Valentina Ambrosini; Luca Fasano; Maurizio Zompatori; Cristina Nanni; Vincenzo Allegri; Stefano Nava; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-06       Impact factor: 9.236

Review 2.  Radiologic Manifestations of Musculoskeletal Sarcoidosis.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Flávio D Silva; Laís Uyeda Aivazoglou; Bruno C Carneiro; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

Review 3.  [Musculoskeletal manifestations of sarcoidosis].

Authors:  P Korsten; G Chehab
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

4.  Refractory sarcoid arthritis in World Trade Center-exposed New York City firefighters: a case series.

Authors:  Konstantinos Loupasakis; Jessica Berman; Nadia Jaber; Rachel Zeig-Owens; Mayris P Webber; Michelle S Glaser; William Moir; Basit Qayyum; Michael D Weiden; Anna Nolan; Thomas K Aldrich; Kerry J Kelly; David J Prezant
Journal:  J Clin Rheumatol       Date:  2015-01       Impact factor: 3.517

Review 5.  Rheumatologic manifestations of sarcoidosis.

Authors:  Nadera J Sweiss; Karen Patterson; Ray Sawaqed; Umair Jabbar; Peter Korsten; Kyle Hogarth; Robert Wollman; Joe G N Garcia; Timothy B Niewold; Robert P Baughman
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

6.  18F-FDG PET/CT in bone sarcoidosis: an observational study.

Authors:  Lucie Demaria; Raphael Borie; Khadija Benali; Eve Piekarski; Julia Goossens; Elisabeth Palazzo; Marine Forien; Philippe Dieudé; Bruno Crestani; Sébastien Ottaviani
Journal:  Clin Rheumatol       Date:  2020-03-20       Impact factor: 2.980

Review 7.  [Sarcoidosis].

Authors:  B C Frye; J C Schupp; T C Köhler; R E Voll; J Müller-Quernheim
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 8.  Bone and bone marrow involvement in sarcoidosis.

Authors:  Ralph Yachoui; Brian J Parker; Thanhcuong T Nguyen
Journal:  Rheumatol Int       Date:  2015-08-07       Impact factor: 2.631

9.  Phalangeal lytic lesion: do not forget osseous sarcoidosis.

Authors:  Eya Cherif; Lamia Ben Hassine; Ines Kechaou; Narjess Khalfallah
Journal:  BMJ Case Rep       Date:  2013-12-04

10.  Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement.

Authors:  Ezra Ross Miller; Christopher H Fanta; Jakob I McSparron; Beatrice Pan; Jonathan S Coblyn; Jeffrey A Sparks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-03-11       Impact factor: 0.670

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.